This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
As my friends at #JPM this week are hearing in San Francisco, AI is part of virtually every biotech and med-tech story. Digging deeper into some of the big trends, Shelly’s observations will also ring authentic to health/care stakeholders… AI is everywhere at CES. But it’s not necessarily useful for everything.
Recent Examples of VC Investment in Wound Care: Corryn Biotechnologies: This UK-based startup raised £550,000 in seed funding to develop a novel wound dressing technology. SolasCure: This UK-based biotech company raised £15 million to develop a wound cleaning product based on an enzyme cloned from medical maggots.
The facility’s location will further EIT’s current partnerships in the Oxford biotech and technology communities, expand collaborations with the University of Oxford, and support the new Ellison Scholars programme.
One of the biggest challenges involves efficiently achieving validations of digital health devices and smartphone apps – that is, ensuring the intended use of a medical device and the management of its data. That change removes a lot of complexity for medical devices companies in China and enables them to become more competitive.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content